Perrigo to Acquire Omega Pharma for €2.48 Million

To expand its over-the-counter products portfolio, Irish consumer healthcare company Perrigo plans to acquire Belgium's Omega Pharma for €2.48 billion, excluding debt.

Perrigo, which was de-listed by CEO Coucke and private equity firm Waterland in 2011, said it would also take on €1.1 million of debt from privately held Omega.
The Belgian company sells prescription-free medicines, healthcare products and personal care items such as wart treatments and suntan lotions.